ClearPoint Neuro, Inc. (CLPT)
Company Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States.
The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance.
It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite.
It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco.
The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020.
ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
| Country | United States |
| Founded | 1998 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 80 |
| CEO | Mr. Joseph Michael Burnett |
Contact Details
Address:
120 S. Sierra Avenue, Suite 100 Solana Beach, California 92075 United States | |
| Phone | (949) 900-6833 |
| Website | clearpointneuro.com |
Stock Details
| Ticker Symbol | CLPT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001285550 |
| CUSIP Number | 18507C103 |
| ISIN Number | US18507C1036 |
| Employer ID | 58-2394628 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joseph Michael Burnett | President, Chief Executive Officer and Director |
| Danilo D'Alessandro | Chief Financial Officer |
| Mazin Sabra | Chief Operating Officer |
| Ellisa Cholapranee | General Counsel and Secretary |
| Jacqueline Keller | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 3, 2023 | 8-K | Current Report |
| Mar 1, 2023 | 10-K | Annual Report |
| Mar 1, 2023 | 8-K | Current Report |
| Feb 9, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 11, 2023 | 8-K | Current Report |
| Dec 14, 2022 | 8-K | Current Report |
| Nov 8, 2022 | 10-Q | Quarterly Report |
| Nov 8, 2022 | 8-K | Current Report |
| Nov 7, 2022 | 8-K | Current Report |
| Sep 20, 2022 | 8-K | Current Report |